Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia

Author:

Păun Monica12,Torres Gustavo3,Țiplica George Sorin24,Cauni Victor Mihail5

Affiliation:

1. Dermatology Research Unit, Colentina Clinical Hospital, 020125 Bucharest, Romania

2. Department of Dermatology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania

3. Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo 05508-220, Brazil

4. Second Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania

5. Department of Urology, Colentina Clinical Hospital, 020125 Bucharest, Romania

Abstract

Background: Androgenetic alopecia (AGA) and alopecia areata (AA) are the most common types of non-cicatricial alopecia. Both diseases have limited effective therapeutic options and affect patient quality of life. Pharmacogenetic tests can help predict the most appropriate treatment option by evaluating the single nucleotide polymorphisms (SNPs) corresponding to genes related to alopecia. The objective of the study was to evaluate and compare selected SNPs and genes in AA and AGA patients from Romania and Brazil. Materials and Methods: We performed a retrospective study regarding the associations between AA and AGA and 45 tag SNPs of 15 genes in 287 Romanian and 882 Brazilian patients. The DNA samples were collected from oral mucosa using a swab. The SNPs were determined by the qPCR technique. Each genetic test displays the subject’s genotype of the selected gene and the prediction of a successful treatment (e.g., genotype AA of the GR-alpha gene is related to a predisposition to normal sensibility to topical glucocorticoid, and, therefore, glucocorticoids should be effective). Results: The GR-alpha, GPR44-2, SULT1A1, and CRABP2 genes were statistically significantly different in Brazil compared to Romania. The SULT1A1 activity that predicts the response to minoxidil treatment showed in our analysis that minoxidil is recommended in half of the cases of AGA and AA. Patients with AGA and a high expression of SRD5A1 or PTGFR-2 may benefit from Dutasteride or Latanoprost treatment, respectively. Most of the studied genes showed no differences between the two populations. Conclusions: The DNA analysis of the patients with alopecia may contribute to a successful treatment.

Publisher

MDPI AG

Subject

General Medicine

Reference40 articles.

1. Androgenetic alopecia: An autosomal dominant disorder;Bergfeld;Am. J. Med.,1995

2. Male androgenetic alopecia;Rathnayake;Expert Opin. Pharmacother.,2010

3. Study of gene expression alteration in male androgenetic alopecia: Evidence of predominant molecular signalling pathways;Michel;Br. J. Dermatol.,2017

4. The genetics of alopecia areata: New approaches, new findings, new treatments;Biran;J. Dermatol. Sci.,2015

5. Alopecia areata—Current understanding and management;Lintzeri;J. Dtsch. Dermatol. Ges.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3